Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Sponsored by University of Pretoria
About this trial
Last updated a year ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Started 7 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Female patient > 16 years
- Presence of vulvo vaginal genital warts: largest tumour diameter > 3 cm OR Tumour on labia minora and labia majora OR bilateral > 1 cm each side OR Tumour in vagina/cervix as well as on vulva > 1 cm lesion each
- HIV negative or HIV infected and CD4 ≥ 300 cells/mm3 OR viral load controlled OR anti retro-viral (ARV) compliant > 6 months
Exclusion Criteria
- Pregnant of planned pregnancy within 6 months
- Not able to comprehend study method or not able to attend all study visits
- Previous HPV vaccination
- Active known opportunistic infection or malignancy including Pneumocystis pneumonia (PCP),Pulmonary tuberculosis (PTB), oesophageal Candida or Kaposi sarcoma or lymphoma
- Known allergy to vaccines or content of vaccine
- Previous radiation for genital warts